Interferon-gamma treatment to improve efficacy of hematopoietic stem cell transplantation for AML and other cancer

— Technology Description

Researchers at Washington University in St. Louis have discovered that interferon-gamma treatment could potentially prevent relapse after hematopoietic stem cell transplantation (HCT) treatment by making the cancer cells more visible to the donor immune cells. This technolog…

Create a Collection
Creating...